The same global food system that is fueling rising obesity rates is also accelerating climate change, according to a sweeping ...

CagriSema would be the first combo GLP-1 if it’s approved, while orforglipron would be the first GLP-1 pill approved for ...

Wegovy maker Novo Nordisk filed for U.S. FDA approval of CagriSema, a once-weekly shot that combines two compounds to treat ...

Orforglipron helped keep weight down when used after initial therapy with an injectable, a new treatment strategy that could ...

The survey showed that while most of the doctors didn’t have top-of-mind awareness of oral semaglutide’s upcoming FDA ...

Participants in a Phase III trial who switched to Eli Lilly’s orforglipron after 72 weeks of treatment with Wegovy or Zepbound largely maintained their weight loss for up to a year.

WorldAtlas has released a list of the ten states with the highest obesity rates. Louisiana was listed as the third state with ...

Soybean oil, used for cooking in more than half of American households, is linked to a higher risk of obesity in a new study.

CNBC's Annika Kim Constantino reports on Eli Lilly after the company said its closely watched obesity pill helped patients ...

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is ...

The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.